These can often be managed by starting with a lower dose (500 mg once a day) and taking it with meals
Byetta and Bydureon (exenatide) : among the earliest GLP-1 medications approved in the United States, available in twice-daily and once-weekly injectable forms
These medications belong to a class of drugs known as GLP-1 receptor agonists (and in the case of Tirzepatide, a dual GLP-1/GIP agonist), which makes them more effective than anything that came before
A family or personal history of melanoma, fair skin, red hair, and freckles represent additional risk factors that signal the need for especially diligent photoprotection and (particularly after puberty) periodic total body skin examinations
The major difference between GLP-1RAs and existing anti-obesity drugs is that GLP-1RAs are assumed to have favorable cardiovascular effects, although whether GLP-1RAs act directly or indirectly on the cardiovascular system is currently unknown [20]